Unified Protocol for Transdiagnostic Treatment of Emotional Disorders for Post-Traumatic Stress Disorder
N/A
Waitlist Available
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Upthe phq-9 will be administered at baseline and follow-up (7 months post-baseline).
Awards & highlights
No Placebo-Only Group
Study Summary
This trial will help emergency responders protect their mental health despite occupational hazards.
Eligible Conditions
- Post Traumatic Stress Disorder
- Anxiety
- Depression
- Alcoholism
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ the phq-9 will be administered at baseline and follow-up (7 months post-baseline).
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the phq-9 will be administered at baseline and follow-up (7 months post-baseline).
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from baseline to follow-up in alcohol misuse severity measured using the Alcohol Use Disorders Identification Test (AUDIT)
Change from baseline to follow-up in anxiety symptom severity measured using the Generalized Anxiety Disorder-7 (GAD-7)
Change from baseline to follow-up in depressive symptoms measured using the Patient Health Questionnaire-9 (PHQ-9)
+5 moreSecondary outcome measures
Change from baseline to follow-up in functional impairment measured using the Work and Social Adjustment Scale (WSAS)
Change from baseline to follow-up in quality of life measured using the World Health Organization Quality of Life (WHOQOL-BREF).
Change from baseline to post-treatment in functional impairment measured using the Work and Social Adjustment Scale (WSAS)
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Transdiagnostic cognitive behavioral therapyExperimental Treatment1 Intervention
Transdiagnostic cognitive behavioral therapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Unified Protocol for Transdiagnostic Treatment of Emotional Disorders
2020
N/A
~70
Find a site
Who is running the clinical trial?
University of PittsburghLead Sponsor
1,674 Previous Clinical Trials
16,301,898 Total Patients Enrolled
Eric C Meyer, PhDStudy Director
University of PittsburghMedia Library
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the scope of this trial in terms of participant numbers?
"Affirmative. Clinicaltrials.gov records that recruitment for this trial began on March 29th, 2022 and was last updated April 26th, 2022. The study is searching for 60 volunteers from 1 medical centre."
Answered by AI
What are the major aims of this research endeavor?
"The core objective of the trial is to evaluate changes in anxiety symptom severity across a 7-month period, as measured by the PHQ-9. Secondary measures include assessing alterations in quality of life (WHOQOL-BREF) and functional impairment (WSAS)."
Answered by AI
Does this research endeavor presently admit new participants?
"Affirmative. The clinicaltrials.gov page illustrates that the study, first listed on March 29th 2022 is currently accepting applications. There are 60 spots available at a single medical centre."
Answered by AI